infectious diseases Flashcards
gram positive cocci - clusters
staph
gram positive cocci - pairs & chains
strep & enterococcus
gram positive rods
listeria & corynebacterium
gram positive anaerobes
peptostrep, propionibacterium, C. diff
atypical bacteria
chlamydia
legionella
mycoplasma
mycobacterium tuberculosis
gram negative anaerobes
bacteroides fragilis
prevotella
gram negative cocci
neisseria
gram negative coccobaccili
acinetobacter, bordatella, moraxella
gram negative rods
HENPEKS, pseudomonas
common resistant pathogens
Kill Each And Every Strong Pathogen
Klebsiella (ESBL, CRE)
E. coli
Acinetobacter
Enterococcus
Staph (MRSA)
Pseudomonas
which antibiotics are hydrophilic
beta lactams
aminoglycosides
vancomycin
daptomycin
polymyxin
which antibiotics are lipophilic
quinolones
macrolides
tetracyclines
rifampin
linezolid
penicillin coverage
natural - gram positive cocci (strep & enterococcus)
antistaph - staph & strep
amino - staph & strep & enterococcus + HNPE
extended penicillins - amino coverage + CAPES + pseudomonas
penicillin side effects & info
seizures, GI upset, diarrhea, rash, hemolytic anemia
antistaph - preferred MSSA coverage, no renal adjustments, nafcillin is a vesicant (hyaluronidase)
cephalosporin coverage
1st - staph/strep (MSSA) + PEK
2nd - staph/strep + HNPEK (cefotetan & cefoxitin add B fragilis coverage)
3rd - staph/strep (resistant) + HNPEK (ceftazidime covers pseudomonas and NO gram positive)
4th - gram positive + HNPEK + CAPES + pseudomonas
5th - + broad gram positive + MRSA
cephalosporin info
CI (ceftriaxone) - biliary sludging in neonates
W (cefotetan) - disulfiram like reaction
SE - seizures, hemolytic anemia, GI upset, diarrhea, rash
carbapenem coverage
MDR gram negative infections
gram positive + gram negative (ESBL) + anaerobes + pseudomonas
ertapenem does not cover pseudomonas, acinetobacter, enterococcus (PEA)
monobactam coverage
gram negative + pseudomonas
aminoglycoside coverage
gram negative + pseudomonas
aminoglycoside dosing for extended interval
4-7 mg/kg/dose (AdjBW unless underweight)
aminoglycoside info
BW - nephrotoxic, ototoxic, NM blockade
quinolone coverage & MOA
DNA gyrase and topo IV
broad spec + atypicals
cipro & levo have pseudomonas
quinolone info
BW - tendon, peripheral neuropathy, seizures
W - QT, hypo/hyperglycemia, psych, photosensitivity
macrolide coverage & MOA
50S
broad spec + atypicals
macrolide info
W - QT, hepatotoxicity, CAD (clarithromycin)
tetracycline coverage & MOA
30S
broad spec + atypicals
doxycycline for CA-MRSA and VRE
tetracycline info
BW - teeth, photosensitivity, DILE (minocycline)
IV:PO is 1:1
sulfonamide coverage & MOA
folic acid pathway
broad spec + shigella, salmonella, strenotrophomonas + OI
NO PSEUDO, ANAEROBE, ATYPICAL
sulfonamide info
5:1 SMP:TMP ratio
BW - SJS, TTP, hemolytic anemia
SE - increased K, photosensitivity, crystalluria
vancomycin MOA & info
D-ala-D-ala
nephro & oto
infusion reaction
do NOT use for MRSA if MIC >2
lipoglycopeptides MOA & info
D-ala and bacterial wall synthesis
cover
BW - fetal risk (telavancin), do not use IV UFH for 120 hours
W - can falsely increase PT/INR and aPTT
dalbavancin & oritavancin are a single dose regimen
daptomycin coverage & info
VRE & MRSA
BW - myopathy, rhabdo, can falsely increase PT/INR
SE - increase CPK
linezolid info
no renal adjustments
1:1
myelosuppression, thrombocytopenia, neuropathy, hypoglycemia
synercid info
VRE faceium ONLY
BW - arthralgias, hyperbilirubinemia
tigecycline coverage
3 Ps
pseudomonas
proteus
providencia
which antibiotic causes gray syndrome
chloramphenicol